Akero Therapeutics (AKRO) had the highest return between August 1, 2022 and September 30, 2022 by a US stock with a market cap of $1B+, returning 227.7%.
| ASSET | DATE | % RETURN |
|---|---|---|
Akero Therapeutics (AKRO) | 8/1/2022 - 9/30/2022 | 227.72% |
Diversified Energy (DEC) | 8/1/2022 - 9/30/2022 | 127.5% |
Enliven Therapeutics (ELVN) | 8/1/2022 - 9/30/2022 | 98.26% |
Rhythm Pharmaceuticals (RYTM) | 8/1/2022 - 9/30/2022 | 96.79% |
Harrow Health (HROW) | 8/1/2022 - 9/30/2022 | 80.96% |
Verona Pharma PLC ADR (VRNA) | 8/1/2022 - 9/30/2022 | 80.25% |
Ardelyx (ARDX) | 8/1/2022 - 9/30/2022 | 72.46% |
YPF Sociedad Anonima (YPF) | 8/1/2022 - 9/30/2022 | 69.67% |
89bio (ETNB) | 8/1/2022 - 9/30/2022 | 63.56% |
NioCorp Developments Ltd Common Stock (NB) | 8/1/2022 - 9/30/2022 | 60.32% |
Applied Opt (AAOI) | 8/1/2022 - 9/30/2022 | 60% |
Viridian Therapeutics (VRDN) | 8/1/2022 - 9/30/2022 | 57.04% |
Xometry (XMTR) | 8/1/2022 - 9/30/2022 | 51.32% |
Bausch Health Companies (BHC) | 8/1/2022 - 9/30/2022 | 49.13% |
International Seaways (INSW) | 8/1/2022 - 9/30/2022 | 47.9% |
Pulse Biosciences (PLSE) | 8/1/2022 - 9/30/2022 | 44.65% |
Genius Sports (GENI) | 8/1/2022 - 9/30/2022 | 43.92% |
Wave Life Sciences (WVE) | 8/1/2022 - 9/30/2022 | 43.25% |
Weatherford International (WFRD) | 8/1/2022 - 9/30/2022 | 42.88% |
Fubotv (FUBO) | 8/1/2022 - 9/30/2022 | 42.57% |
Limbach (LMB) | 8/1/2022 - 9/30/2022 | 42.06% |
SS Innovations International Inc Common Stock (SSII) | 8/1/2022 - 9/30/2022 | 41.94% |
Alnylam Pharmaceuticals (ALNY) | 8/1/2022 - 9/30/2022 | 41.14% |
Precigen (PGEN) | 8/1/2022 - 9/30/2022 | 39.47% |
Nutanix (NTNX) | 8/1/2022 - 9/30/2022 | 38.96% |
